Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation: PRIME study
Background: The morbidity and mortality of patients with functional mitral regurgitation (MR)
remain high, but no pharmacological therapy has been proven effective. The hypothesis of …
remain high, but no pharmacological therapy has been proven effective. The hypothesis of …
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation
DH Kang, SJ Park, SH Shin, GR Hong, S Lee, MS Kim… - Circulation, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> The morbidity and mortality of
patients with functional mitral regurgitation (MR) remain high, but no pharmacological …
patients with functional mitral regurgitation (MR) remain high, but no pharmacological …
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation PRIME Study
DH Kang, SJ Park, SH Shin, GR Hong, S Lee… - …, 2019 - scholarworks.bwise.kr
BACKGROUND: The morbidity and mortality of patients with functional mitral regurgitation
(MR) remain high, but no pharmacological therapy has been proven effective. The …
(MR) remain high, but no pharmacological therapy has been proven effective. The …
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation
DH Kang, SJ Park, SH Shin, GR Hong, S Lee, MS Kim… - 2019 - ir.ymlib.yonsei.ac.kr
BACKGROUND: The morbidity and mortality of patients with functional mitral regurgitation
(MR) remain high, but no pharmacological therapy has been proven effective. The …
(MR) remain high, but no pharmacological therapy has been proven effective. The …
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation
DH Kang - Circulation, 2019 - Am Heart Assoc
BACKGROUND: The morbidity and mortality of patients with functional mitral regurgitation
(MR) remain high, but no pharmacological therapy has been proven effective. The …
(MR) remain high, but no pharmacological therapy has been proven effective. The …
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation
DH Kang, SJ Park, SH Shin, GR Hong, S Lee, MS Kim… - 2019 - pubmed.ncbi.nlm.nih.gov
Background The morbidity and mortality of patients with functional mitral regurgitation (MR)
remain high, but no pharmacological therapy has been proven effective. The hypothesis of …
remain high, but no pharmacological therapy has been proven effective. The hypothesis of …
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation.
DH Kang, SJ Park, SH Shin, GR Hong, S Lee, MS Kim… - Circulation, 2019 - europepmc.org
Background The morbidity and mortality of patients with functional mitral regurgitation (MR)
remain high, but no pharmacological therapy has been proven effective. The hypothesis of …
remain high, but no pharmacological therapy has been proven effective. The hypothesis of …